Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
0.9517
+0.0052 (0.55%)
At close: Sep 11, 2026, 4:00 PM EDT
0.9520
+0.0003 (0.03%)
After-hours: Sep 11, 2026, 7:33 PM EDT
Akebia Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Westpark Capital | Westpark Capital | Buy Initiates $4.5 | Buy | Initiates | $4.5 | +372.84% | Sep 8, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $4 | Buy | Maintains | $4 | +320.30% | Aug 17, 2026 |
| Leerink Partners | Leerink Partners | Hold Downgrades $1 | Hold | Downgrades | $1 | +5.08% | Aug 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $6 | Buy | Reiterates | $6 | +530.45% | Aug 6, 2026 |
| BTIG | BTIG | Buy Reiterates $4 | Buy | Reiterates | $4 | +320.30% | Aug 6, 2026 |